Investor RelationsPress center
  1. Home
  2. Laboratory Diagnostics
  3. COVID-19 Public Health Topics
  4. High-throughput SARS-CoV-2 Antigen Testing in Schools

COVID-19 Testing in Schools: a Video Case Study

Fast, accurate, and cost-effective testing for students and faculty 

As the pandemic persists, demand for testing continues to increase, placing great pressure on large organizations and communities to efficiently identify COVID-19 infection.. Lab-based antigen testing can be easily integrated on currently available high-throughput instruments already being used for routine diagnostic testing at clinics, reference labs, and hospitals or can be installed at a mass testing site.

Hear how laboratories can easily and quickly help support large-scale testing in schools, universities, and other large institutions.

Video Case Study: Lab Antigen Testing in Schools

"We’ve learned that testing to identify emerging infection is key, and that it must be done frequently and deliver same-day or next day results to be most effective."

Why choose high-volume antigen testing for schools?

Detecting asymptomatic infections

Detect asymptomatic infections

Antigen testing can aid in fast detection of currently infected students, faculty, and staff, including those who are asymptomatic.

Lab-based antigen testing can be easily integrated on currently available high-throughput instruments already in use for routine diagnostic testing

Labs contribute to school safety

High-volume, central laboratory-based testing helps schools and families feel confident while adhering to their COVID-19 safety protocols.

Automated laboratory reports can satisfy reporting requirements to the appropriate public health authorities

The advantages of high-volume testing for schools

High-throughput antigen assays can test up to several hundred samples a day and get accurate results the same day2.

“With antigen testing, we managed to provide results on the same day…that was our commitment, and we managed to do it.”1

Marco Marques 

Technical Director, Laboratorio Affidea

Marco Marques 

Technical Director, Laboratorio Affidea

“The Siemens Healthineers test is excellent because using automated analyzers, which we are already using for other testing, meant that we only had to adapt the reagents to the automated technology.”1

Germano de Sousa

Chairman of the Board of Directors Laboratorio Germano de Sousa

Germano de Sousa

Chairman of the Board of Directors Laboratorio Germano de Sousa

Siemens Healthineers is committed to monitoring all current and emerging Variants of Concern (VOC), including Delta and Omicron variants to ensure the test results remain accurate and reliable.

1
Disclaimer: The statements by Siemens Healthineers’ customers described herein are based on results that were achieved in the customer's unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results
2
Dependent upon test mix. Atellica IM SARS-CoV2Ag test throughput is 200 tests/hour.

* This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories; this product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. Product availability may vary from country to country and is subject to local regulatory requirements.